0001950047-23-000440.txt : 20230505 0001950047-23-000440.hdr.sgml : 20230505 20230505172549 ACCESSION NUMBER: 0001950047-23-000440 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230505 DATE AS OF CHANGE: 20230505 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 23895103 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Mesa Nilda CENTRAL INDEX KEY: 0001756697 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O UNITED THERAPEUTICS CORPORATION STREET 2: 1040 SPRING STREET CITY: SILVER SPRING STATE: MD ZIP: 20910 144 1 primary_doc.xml 144 0001756697 XXXXXXXX LIVE 0001082554 UNITED THERAPEUTICS CORPORATION 000-26301 1040 SPRING STREET SILVER SPRING MD 20910 (301) 608-9292 NILDA MESA Director Common Morgan Stanley Smith Barney LLC

1 New York Plaza 38th Floor New York NY 10004

374 80337.07 46846538 05/05/2023 NASD Common 06/26/2020 Restricted Stock Issuer N 234 06/26/2020 None Common 06/26/2021 Restricted Stock Issuer N 140 06/26/2021 None Y 05/05/2023 /s/ Nilda Mesa